- Home
- / Sumitomo Pharma
Sumitomo Pharma
Stock Price
¥494
2023-11-24
Market Capitalization
¥196.3 B
2023-11-24
Revenue
¥555.5 B
FY, 2023
Sumitomo Pharma Summary
Company Summary
- Overview
- Sumitomo Pharma (住友ファーマ株式会社) is a company that manufactures and sells pharmaceuticals, veterinary medicines, and food additives. It researches and develops therapeutic agents, animal health and personal care products, food ingredients, and regenerative medicines. The company provides drugs in therapeutic areas such as psychiatry, diabetes, neurology, and oncology.
- Type
- Public
- Status
- Active
- Founded
- 1897
- HQ
- Osaka, JP | view all locations
- Cybersecurity rating
Table of Contents
Key People
LocationsView all
25 locations detected
Osaka, Osaka HQ
Japan
6-8, Doshomachi 2-chome
Marlborough, MA
United States
84 Waterford Dr
Jiangsu
China
No.115 QingQiu Street
Shanghai, Shang Hai Shi
China
Tower A, China Overseas International Center, Lane 838, South Huangpi Road
Fukuoka, Fukuoka
Japan
Kamiyo Hakata-chuo Building, 7-21, Chuo-gai
Hiroshima, Hiroshima
Japan
Asahi Seimei Hiroshima Ebisucho Building, 4-21, Ebisu-cho
Sumitomo Pharma Financials
Summary Financials
- Revenue (Q1, 2024)
- ¥75.7B
- Gross profit (Q1, 2024)
- ¥60.8B
- Net income (Q1, 2024)
- (¥38.9B)
- Cash (Q1, 2024)
- ¥94.5B
- EBIT (Q1, 2024)
- (¥51.6B)
- Enterprise value
- $473.6B